During the preparation of the current study, Chu et al. published two head and neck carcinomas harboring FGFR::TACC fusions: an HPV-related multiphenotypic sinonasal carcinoma carrying an FGFR2::TACC2 fusion with concurrent non-16/18 high-risk HPV, and one FGFR3::TACC3 fusion–positive keratinizing SCC of the parotid gland [38]. The gene discussed is FGFR2; the disease is nasal cavity and paranasal sinus carcinoma.